In PSP, we averaged 18F-AV-1451 BPND across midbrain and basal ganglia, reflecting the more focal distribution of disease and our hypotheses about dissociated functional effects of cortical and subcortical tau (Passamonti et al., 2017). The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.